What does an ACTH (cosyntropin) stimulation test with a baseline cortisol of 7.27 µg/dL and a 30‑minute cortisol of 8.5 µg/dL (60‑minute result pending) indicate, and what is the appropriate treatment?

ACTH Stimulation Test Result Interpretation

This test is diagnostic of adrenal insufficiency and requires immediate initiation of glucocorticoid replacement therapy. With a baseline cortisol of 7.27 µg/dL and a 30-minute cortisol of only 8.5 µg/dL, the adrenal glands have failed to respond adequately to ACTH stimulation, confirming the diagnosis regardless of the 60-minute result.

Diagnostic Interpretation

The FDA label for cosyntropin clearly states that stimulated plasma cortisol levels of less than 18 µg/dL at 30- or 60-minutes post-injection are suggestive of adrenocortical insufficiency 1. Your patient's 30-minute cortisol of 8.5 µg/dL falls dramatically below this threshold—representing less than half the minimum required response.

Key Diagnostic Points:

• Baseline cortisol of 7.27 µg/dL: This is already concerning, as the Endocrine Society guidelines note that cortisol <5 µg/dL (140 nmol/L) combined with elevated ACTH is highly suggestive of primary adrenal insufficiency even before stimulation testing 2

• 30-minute cortisol of 8.5 µg/dL: This represents only a 1.23 µg/dL rise from baseline—a profoundly inadequate response. The adrenal glands are essentially non-responsive to maximal ACTH stimulation

• The 60-minute value is unnecessary for diagnosis: Multiple studies demonstrate that patients who fail to reach threshold at 30 minutes virtually never achieve adequate response at 60 minutes 3, 4, 5, 6. Research shows that only 0.6% of patients who meet the cutoff at 30 minutes fail at 60 minutes, but the reverse (failing at 30 but passing at 60) occurs in 13-14% of cases 3, 4. In your patient's case, with such a profoundly low 30-minute value, the 60-minute result will not change the diagnosis

Immediate Management Algorithm

1. Start Glucocorticoid Replacement Immediately

The Endocrine Society strongly recommends that in patients with severe adrenal insufficiency symptoms or adrenal crisis, immediate therapy with IV hydrocortisone at an appropriate stress dose should be given prior to the availability of diagnostic test results 2. While awaiting full evaluation:

• Standard replacement: Hydrocortisone 15-25 mg/day in divided doses (typically 10 mg morning, 5 mg afternoon, 5 mg evening) 2
• If symptomatic or acutely ill: Start with stress-dose hydrocortisone 100 mg IV, then 50 mg IV every 6-8 hours until stable

2. Determine Primary vs. Secondary Adrenal Insufficiency

Measure plasma ACTH level (if not already done):

• ACTH >66 pmol/L (>2-fold above upper limit of normal): Confirms primary adrenal insufficiency (Addison's disease) 2

  • Will require both glucocorticoid AND mineralocorticoid (fludrocortisone 0.05-0.2 mg daily) replacement
  • Investigate etiology: autoimmune adrenalitis (most common), tuberculosis, adrenal hemorrhage, infiltrative disease

• ACTH low or inappropriately normal: Indicates secondary adrenal insufficiency

  • Requires glucocorticoid replacement only (no mineralocorticoid needed)
  • Evaluate pituitary function and imaging

3. Patient Education on Adrenal Crisis Prevention

This is critical for mortality reduction:

• Stress-dose steroids during illness, surgery, or trauma
• Medical alert identification
• Emergency injection kit (hydrocortisone 100 mg IM)
• Sick-day rules

Critical Pitfalls to Avoid

Do not wait for the 60-minute result to initiate treatment. The 30-minute value of 8.5 µg/dL is definitively diagnostic, and delayed treatment increases morbidity and mortality 2.

Do not assume this is secondary adrenal insufficiency without measuring ACTH. The baseline cortisol of 7.27 µg/dL could represent either primary or secondary disease—ACTH level is essential for proper management, as primary disease requires mineralocorticoid replacement 2.

Be aware of assay-specific cutoffs. While the traditional threshold is 18 µg/dL, newer immunoassays may use lower cutoffs (14.6-15.6 µg/dL) 7, 8. However, your patient's value of 8.5 µg/dL is abnormal by any standard.

Quality of Life Considerations

The Endocrine Society guidelines note that glucocorticoid dosing <30 mg/day hydrocortisone equivalent does not differ significantly in health-related quality of life outcomes compared to higher doses 2. Start with physiologic replacement doses and titrate based on clinical response, avoiding overreplacement which increases cardiovascular and metabolic risks.